Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
Effect of Locally Delivered Antioxidants as An Adjunct to Non-surgical Periodontal Therapy on GCF Level of Oxidative Stress Marker; Protein Carbonyl
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Sep 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2016
CompletedFirst Submitted
Initial submission to the registry
June 24, 2017
CompletedFirst Posted
Study publicly available on registry
June 29, 2017
CompletedJune 29, 2017
June 1, 2017
1.1 years
June 24, 2017
June 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GCF level of protein carbonyl
to assess GCF level of protein carbonyl following local delivery of sustained release form of lycopene as an adjunct to scaling and root planning (SRP) in management of severe chronic periodontitis patients.
1 month
Secondary Outcomes (6)
Plaque index
6 months
Modified gingival index
6 months
Probing depth
6 months
Clinical attachment loss
6 minths
Radiographic changes
6 months
- +1 more secondary outcomes
Study Arms (3)
Group I: Lycopene + SRP
EXPERIMENTALLycopene, 0.1 ml injected once in the periodontal pocket after scaling and root planing
Group II: SRP only
ACTIVE COMPARATORScaling and root planing only without lycopene
Group III: healthy subjects
NO INTERVENTIONNo intervention
Interventions
Eligibility Criteria
You may qualify if:
- All subjects were free from any systemic diseases.
- Subjects for group I and II were suffering from severe chronic periodontitis (Armitage et al., 1999).
- Group III included subjects with clinically healthy periodontium.
- All subjects were between 35-60 years old.
- Both genders were included.
- Subjects were able to return for follow up visits.
- Subjects agreed to sign a written consent after the nature of the study was explained.
You may not qualify if:
- History of scaling and root planing or periodontal surgery \< 6 months prior to initiation of the study.
- History of administration of antimicrobial drugs or over the counter antioxidants like Vit C, Vit B, β-carotene \< 6 months prior to the baseline examination.
- Subjects who reported any side effects or drug allergies from antioxidants.
- Subjects with mobile teeth, abscesses and defected restorations related to the affected sites.
- Subjects with para-functional habits.
- Pregnant and lactating females.
- Smokers, alcoholic and drug abusers.
- Prisoner.
- Mentally retarded patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maie Sami tawfiklead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ahmed Y Gamal, PhD
AinShams university
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 24, 2017
First Posted
June 29, 2017
Study Start
September 28, 2015
Primary Completion
November 10, 2016
Study Completion
December 14, 2016
Last Updated
June 29, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share